Michael Kauffman - Insider Trading & Ownership

Entity
Individual
Location
C/O Karyopharm Therapeutics Inc., 85 Wells Avenue, Second Floor, Newton, MA
Summary
The estimated net worth of Michael Kauffman is at least $1.36M dollars as of August 23, 2024. Michael Kauffman is the Director of Karyopharm Therapeutics Inc. and owns shares of Karyopharm Therapeutics Inc. (KPTI) stock worth about $1.32M. Michael Kauffman is the Director of Verastem, Inc. and owns shares of Verastem, Inc. (VSTM) stock worth about $28.5K. Michael Kauffman is the Director of Adicet Bio, Inc. and owns shares of Adicet Bio, Inc. (ACET) stock worth about $8.44K.
All Insider Reports
All Insider Reports

Ownership of Michael Kauffman

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
KPTI Karyopharm Therapeutics Inc. Director $1.32M Feb 28, 2022
VSTM Verastem, Inc. Director $28.5K Jun 18, 2024
ACET Adicet Bio, Inc. Director $8.44K -$8.44K -50% Aug 21, 2024
KZR Kezar Life Sciences, Inc. Director Jun 20, 2024

Insider Transactions Reported by Michael Kauffman:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.